Translational research and the changing face of breast cancerDOWSETT, Mitch.Breast cancer research and treatment. 2004, Vol 87, pp S1-S2, issn 0167-6806, SUP1Conference Paper

Aromatase inhibitors in breast cancerSMITH, Ian E; DOWSETT, Mitch.The New England journal of medicine. 2003, Vol 348, Num 24, pp 2431-2442, issn 0028-4793, 12 p.Article

Overview of adjuvant trials of aromatase inhibitors in early breast cancerINGLE, James N.Steroids. 2011, Vol 76, Num 8, pp 765-767, issn 0039-128X, 3 p.Conference Paper

Proliferation marker Ki-67 in early breast cancerURRUTICOECHEA, Ander; SMITH, Ian E; DOWSETT, Mitch et al.Journal of clinical oncology. 2005, Vol 23, Num 28, pp 7212-7220, issn 0732-183X, 9 p.Article

Molecular endocrinology and breast cancer ― A reed before the wind lives on (a tribute to Professor Mike Reed)MILLER, W. R.Steroids. 2011, Vol 76, Num 8, pp 745-749, issn 0039-128X, 5 p.Conference Paper

Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitorsLØNNING, Per Eystein; HAYNES, Benjamin P; DOWSETT, Mitch et al.European journal of cancer (1990). 2014, Vol 50, Num 6, pp 1055-1064, issn 0959-8049, 10 p.Article

Biomarkers for the clinical management of breast cancer: International perspectivePATANI, Neill; MARTIN, Lesley-Ann; DOWSETT, Mitch et al.International journal of cancer (Print). 2013, Vol 133, Num 1, pp 1-13, issn 0020-7136, 13 p.Article

Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal womenKEY, Timothy J.Steroids. 2011, Vol 76, Num 8, pp 812-815, issn 0039-128X, 4 p.Conference Paper

The combination of VEGF inhibitors and anti-oestrogen therapies in breast cancerBANERJEE, Susana.Steroids. 2011, Vol 76, Num 8, pp 807-811, issn 0039-128X, 5 p.Conference Paper

Influences on circulating oestrogens in postmenopausal women : Relationship with breast cancerKENDALL, Anne; FOLKERD, Elizabeth J; DOWSETT, Mitch et al.Journal of steroid biochemistry and molecular biology. 2007, Vol 103, Num 2, pp 99-109, issn 0960-0760, 11 p.Article

Pharmacology of arthralgia with estrogen deprivationLINTERMANS, Anneleen; NEVEN, Patrick.Steroids. 2011, Vol 76, Num 8, pp 781-785, issn 0039-128X, 5 p.Conference Paper

Binding features of steroidal and nonsteroidal inhibitorsYANYAN HONG; RASHID, Rumana; SHIUAN CHEN et al.Steroids. 2011, Vol 76, Num 8, pp 802-806, issn 0039-128X, 5 p.Conference Paper

Influence of Sex Hormones on Cancer ProgressionFOLKERD, Elizabeth J; DOWSETT, Mitch.Journal of clinical oncology. 2010, Vol 28, Num 26, pp 4038-4044, issn 0732-183X, 7 p.Article

Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status : An hypothesis-generating studyDOWSETT, Mitch; CUZICK, Jack; WALE, Chris et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7512-7517, issn 0732-183X, 6 p.Article

Biological characteristics of the pure antiestrogen fulvestrant : overcoming endocrine resistanceDOWSETT, Mitch; NICHOLSON, Robert I; PIETRAS, Richard J et al.Breast cancer research and treatment. 2005, Vol 93, pp S11-S18, issn 0167-6806, SUP1Article

The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trialATKINSON, Charlotte; COMPSTON, Juliet E; DAY, Nicholas E et al.The American journal of clinical nutrition. 2004, Vol 79, Num 2, pp 326-333, issn 0002-9165, 8 p.Article

Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancerSESTAK, Ivana; HARVIE, Michelle; HOWELL, Anthony et al.Breast cancer research and treatment. 2012, Vol 134, Num 2, pp 727-734, issn 0167-6806, 8 p.Article

Life following aromatase inhibitors - : where now for endocrine sequencing?JOHNSTON, Stephen R; MARTIN, Lesley-Ann; DOWSETT, Mitch et al.Breast cancer research and treatment. 2005, Vol 93, pp S19-S25, issn 0167-6806, SUP1Article

Comparison of the selective estrogen receptor modulator arzoxifene (LY353381) with tamoxifen on tumor growth and biomarker expression in an MCF-7 human breast cancer xenograft modelDETRE, Simone; RIDDLER, Sharon; SALTER, Janine et al.Cancer research (Baltimore). 2003, Vol 63, Num 19, pp 6516-6522, issn 0008-5472, 7 p.Article

Suppression of Plasma Estrogen Levels by Letrozole and Anastrozole Is Related to Body Mass Index in Patients With Breast CancerFOLKERD, Elizabeth J; DIXON, J. Michael; RENSHAW, Lorna et al.Journal of clinical oncology. 2012, Vol 30, Num 24, pp 2977-2980, issn 0732-183X, 4 p.Article

Aromatase in human lung carcinomaVERMA, Mohit K; MIKI, Yasuhiro; SASANO, Hironobu et al.Steroids. 2011, Vol 76, Num 8, pp 759-764, issn 0039-128X, 6 p.Conference Paper

Twenty-year follow-up of the royal marsden randomized, double-blinded tamoxifen breast cancer prevention trialPOWLES, Trevor J; ASHLEY, Sue; TIDY, Alwynne et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 4, pp 283-290, issn 0027-8874, 8 p.Article

Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancerDAVIES, Giles; SALTER, Janine; HILLS, Margaret et al.Clinical cancer research. 2003, Vol 9, Num 7, pp 2651-2656, issn 1078-0432, 6 p.Article

Importance of PI3-kinase pathway in response/resistance to aromatase inhibitorsMA, Cynthia X; CROWDER, Robert J; ELLIS, Matthew J et al.Steroids. 2011, Vol 76, Num 8, pp 750-752, issn 0039-128X, 3 p.Conference Paper

Enhancing Endocrine Response With Novel Targeted Therapies : Why Have the Clinical Trials to Date Failed to Deliver on the Preclinical Promise?JOHNSTON, Stephen R. D; LEARY, Alexandra; MARTIN, Lesley-Ann et al.Cancer. 2008, Vol 112, Num 3, pp 710-717, issn 0008-543X, 8 p., SUPConference Paper